White label ELPA - ClinicalTrials.eu

Study on MK-6194 for Adults with Systemic Lupus Erythematosus

Not recruiting

4 1
Investigated Drugs:
- Mk-6194
Study on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Bladder cancer
Investigated Drugs:
+2
Study on the Safety and Effectiveness of Vepdegestrant and Samuraciclib for Adults with ER+ Advanced or Metastatic Breast Cancer

Not recruiting

1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- Samuraciclib
- (3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
Study of Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Not recruiting

2 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
Study on the Safety and Efficacy of Viltolarsen for Boys with Duchenne Muscular Dystrophy

Not recruiting

3 1 1
Investigated Drugs:
- Viltolarsen
Long-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II

Not recruiting

3 1 1
Investigated Diseases:
- Hereditary angioedema with C1 esterase inhibitor deficiency
Investigated Drugs:
- Sebetralstat
+7
Study on the Effectiveness and Safety of Osimertinib for Patients with EGFR Mutation-Positive Stage II-IIIB Non-Small Cell Lung Cancer After Tumor Removal

Not recruiting

2 1 1 1
Investigated Drugs:
- Osimertinib
Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

Not recruiting

3 1 1 1
Investigated Diseases:
- Hepatic cirrhosis
Investigated Drugs:
- Human Serum Albumin
+5
Study on the Safety and Effects of Englumafusp Alfa with Obinutuzumab and Glofitamab for Patients with Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma

Not recruiting

1 1 1 1
Investigated Diseases:
- B-cell lymphoma refractory
- B-cell lymphoma
Investigated Drugs:
Study of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Not recruiting

4 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies